drugset / Trial / NCT01187264
Dose Ranging Study to Compare the Efficacy and Safety of Methotrexate in Plaque Type Psoriasis
Phase 4
Completed
100 enrolled
Post Graduate Institute of Medical Education and Research, Chandigarh
RandomizedParallel-groupQuadruple-blindTreatment
Summary
In this study the investigators intend to compare the efficacy and safety of two fixed doses of once weekly oral methotrexate in a prospective randomized double blind manner in patients with severe plaque type psoriasis.
Timeline
- Start
- 2008-08
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methotrexate | Small molecule | 10 mg | Oral |
| Comparator | Methotrexate | Small molecule | 25 mg | Oral |